IceCure Medical announces 1-for-30 reverse share split to regain Nasdaq compliance
PUBT · 21h ago
Share
Listen to the news
- IceCure Medical to execute a 1-for-30 reverse share split to lift its Nasdaq share price above the $1 minimum bid rule.
- Shares begin trading on a split-adjusted basis at the market open June 4, 2026; ticker remains ICCM; new CUSIP M53071201.
- Move targets Nasdaq compliance by the Nov. 9, 2026 deadline; part of a broader capital markets strategy.
- Issued shares expected to drop to about 2,806,701 from 84,201,034; authorized share capital unchanged at 2.5 billion shares.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IceCure Medical Ltd. published the original content used to generate this news brief on June 02, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved